Literature DB >> 17133061

Histology of posterior lamellar keratoplasty.

R Ken Lord1, Francis W Price, Marianne O Price, Liliana Werner, Nick Mamalis.   

Abstract

PURPOSE: To report histology of a posterior lamellar graft performed to treat clinically significant endothelial disease in a patient with Fuchs dystrophy.
METHODS: A 78-year-old patient with Fuchs dystrophy underwent posterior lamellar keratoplasty (PLK), the original form of endothelial keratoplasty performed with manual lamellar dissection of the recipient and donor corneas. Eighteen months later, the patient had herpes simplex virus keratitis and graft rejection episodes. One year after the infection resolved (2.5 years after PLK), penetrating keratoplasty was performed, and the excised corneal button was examined.
RESULTS: Histopathologic evaluation of the corneal button showed no discernible interface, opacity, or gapping between the anterior host stromal tissue and PLK donor tissue or any signs of significant migration of donor endothelial cells onto recipient tissue.
CONCLUSION: This PLK histology showed firm attachment with no visible interface between the posterior donor and anterior host stromal tissue. Surprisingly, no significant donor endothelial cell migration was detected on adjacent recipient tissue where Descemet membrane had been excised or where endothelial cells were lost as a result of the procedure.

Entities:  

Mesh:

Year:  2006        PMID: 17133061     DOI: 10.1097/01.ico.0000230322.21332.20

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  Histology of corneal wound healing after deep lamellar endothelial keratoplasty.

Authors:  Chaoran Zhang; Jianjiang Xu; Rongjia Chen
Journal:  Clin Ophthalmol       Date:  2008-03

2.  Keratocyte apoptosis and not myofibroblast differentiation mark the graft/host interface at early time-points post-DSAEK in a cat model.

Authors:  Adam J Weis; Krystel R Huxlin; Christine L Callan; Margaret A DeMagistris; Holly B Hindman
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.